These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31045458)

  • 1. Genetic polymorphisms of PPAR genes and human cancers: evidence for gene-environment interactions.
    Dhaini HR; Daher Z
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2019; 37(3):146-179. PubMed ID: 31045458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers.
    Yang Y; Burke RV; Jeon CY; Chang SC; Chang PY; Morgenstern H; Tashkin DP; Mao J; Cozen W; Mack TM; Rao J; Zhang ZF
    Lung Cancer; 2014 Sep; 85(3):449-56. PubMed ID: 25043640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
    Latruffe N; Vamecq J
    Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARs at the crossroads of lipid signaling and inflammation.
    Wahli W; Michalik L
    Trends Endocrinol Metab; 2012 Jul; 23(7):351-63. PubMed ID: 22704720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease?
    Denning GM; Stoll LL
    Pediatr Pulmonol; 2006 Jan; 41(1):23-34. PubMed ID: 16267824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pan-cancer mutational landscape of the PPAR pathway reveals universal patterns of dysregulated metabolism and interactions with tumor immunity and hypoxia.
    Chang WH; Lai AG
    Ann N Y Acad Sci; 2019 Jul; 1448(1):65-82. PubMed ID: 31215667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives.
    Laganà AS; Vitale SG; Nigro A; Sofo V; Salmeri FM; Rossetti P; Rapisarda AM; La Vignera S; Condorelli RA; Rizzo G; Buscema M
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The peroxisome proliferator-activated receptors under epigenetic control in placental metabolism and fetal development.
    Lendvai Á; Deutsch MJ; Plösch T; Ensenauer R
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E797-810. PubMed ID: 26860983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview on biological mechanisms of PPARs.
    Kota BP; Huang TH; Roufogalis BD
    Pharmacol Res; 2005 Feb; 51(2):85-94. PubMed ID: 15629253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of the human hepatoblastoma cell lines inducibly expressing peroxisome proliferator-activated receptors (PPARs)].
    Tachibana K
    Yakugaku Zasshi; 2007 Aug; 127(8):1223-9. PubMed ID: 17666873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nuclear Receptor PPARs and magnesium].
    Fujii H
    Clin Calcium; 2005 Nov; 15(11):52-64. PubMed ID: 16272614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulation of fat metabolism by PPARs].
    Liu XF; Li H
    Yi Chuan; 2006 Feb; 28(2):243-8. PubMed ID: 16520324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphisms of PPARs and metabolic disorders].
    Araki E; Igata M; Motoshima H; Tsuruzoe K
    Nihon Rinsho; 2005 Apr; 63(4):617-22. PubMed ID: 15828229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARs: fatty acid sensors controlling metabolism.
    Poulsen Ll; Siersbæk M; Mandrup S
    Semin Cell Dev Biol; 2012 Aug; 23(6):631-9. PubMed ID: 22273692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?
    Gupta M; Mahajan VK; Mehta KS; Chauhan PS; Rawat R
    Arch Dermatol Res; 2015 Nov; 307(9):767-80. PubMed ID: 25986745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.
    Yessoufou A; Wahli W
    Swiss Med Wkly; 2010; 140():w13071. PubMed ID: 20842602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of peroxisome proliferator-activated receptors (PPAR) in carcinogenesis].
    Knapp P; Jarzabek K; Błachnio A; Zbroch T
    Ginekol Pol; 2006 Aug; 77(8):643-51. PubMed ID: 17076197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peroxisome proliferator activated receptors (PPAR) and insulin sensitivity: experimental studies].
    Haluzík MM; Haluzík M
    Cesk Fysiol; 2006; 55(4):163-8. PubMed ID: 17685022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.